We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fevertree Drinks Plc | LSE:FEVR | London | Ordinary Share | GB00BRJ9BJ26 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-18.00 | -1.51% | 1,171.00 | 1,173.00 | 1,176.00 | 1,194.00 | 1,168.00 | 1,194.00 | 253,856 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Wine & Alcoholic Bev-whsl | 364.4M | 15.4M | 0.1320 | 88.86 | 1.37B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/6/2017 13:17 | The 3 analysts offering 12 month price targets for Fevertree Drinks PLC have a median target of 1,865.00, with a high estimate of 1,950.00 and a low estimate of 1,850.00. The median estimate represents a 8.81% increase from the last price of 1,714.00. from the FT | christh | |
12/6/2017 13:15 | A reminder.... As of Jun 09, 2017, the consensus forecast amongst 4 polled investment analysts covering Fevertree Drinks PLC advises that the company will outperform the market. | christh | |
12/6/2017 12:39 | 3 Trade mms need shares !! | ccr1958 | |
12/6/2017 12:37 | Yes christh, X3 ;) | ccr1958 | |
12/6/2017 12:16 | ccr1958 12 Jun '17 - 12:07 - 524 of 525 yes and a few 1 Trades going thru !! Was that you with just 1 share? | christh | |
12/6/2017 12:11 | A big mop up from the institutions who never managed to build a stake. More institutions come on board in my opinion. A growth stock like no other. | christh | |
12/6/2017 12:07 | yes and a few 1 Trades going thru !! | ccr1958 | |
12/6/2017 12:05 | Ok for those of you that want to pick up the next FEVR look at the growth being delivered here. | pet lover | |
12/6/2017 12:02 | Wow, A big buy of 67,734 shares at £17.11. Anyone noticed that... | christh | |
12/6/2017 11:52 | A great buying opportunity. It has come down from £17.66 to £16.40 The results not far will push this to £20 at least. | christh | |
12/6/2017 10:56 | I remove the offer signs from Fentimens! apad | apad | |
12/6/2017 10:36 | Completely agree Christh. Every time I'm in a supermarket I make a point of checking the mixer shelves and rarely are Fevertree fully stocked. | villarich | |
12/6/2017 10:13 | Villarich, that proves that is ever so popular and the demand is high. So you know you are in a quality stock! | christh | |
12/6/2017 08:39 | Thx for the little shake ,I have doubled my holding this am :) | ccr1958 | |
12/6/2017 08:35 | Heavily oversold. I do expect a bounce to £17.30 | christh | |
11/6/2017 21:37 | Reading apad's reference when you see the competition I would be pessimistic about Fever Tree's chances of competing! However, it does and does it well. Maybe there's some other secret we haven't latched onto here? Maybe Americans' taste buds are different from Brits'? They certainly are for chocolate where chocolate producers, e.g. KitKat, make a different taste chocolate for consumers in Britain, Europe, the Far East and America etc. Whatever, the proof of the tonic is in the numbers! | sogoesit | |
11/6/2017 17:22 | A few mentions here, hxxps://www.tripadvi search USA, Fevertree edit, link too long | bamboo2 | |
11/6/2017 13:52 | The yoodle market is quite busy! portlandfoodanddrink apad | apad | |
11/6/2017 12:39 | I travel to the States quite a bit ,I will report back ! | ccr1958 | |
11/6/2017 09:42 | I echo the comments of posters here who are questioning why the consensus forecasts for 2017 show a massive deceleration in sales growth.None of us has a crystal ball, but we all make investment decisions based on our experience, insight and future expectations. My view is that the consensus forecasts are way too low. In the UK you can clearly see momentum continuing to build on the base of the strengthening brand awareness. The big unknown is the non uk current growth picture. This is what will ultimately determine how much further the share price has to go. We all make our own choices. For me, after taking all current info into consideration, including the valuation, I'm going nowhere. Courage required here in my opinion. | devalpha | |
10/6/2017 19:19 | Interesting stuff Sogoesit and APAD. I will await the H1 results to see whether revenue, margins and earnings support the idea that the City (and house broker) are wrong in forecasting such a marked fall-off in the rate of FEVR's growth. | henchard | |
10/6/2017 17:37 | I'm afraid not apad, I do most of my research experience in hotels, bars and supermarkets! And I travel far-eastwards, seldom to the US. Dark spirits will be a mystery to me I'm afraid although I drink the Ginger Ale as I like ginger tastes, in cooking as well. Yes, my portfolio had also got to 20% Fevr a few months ago but, with other stocks temporarily outperforming, it has dropped back to 13%. I leave things to re-balance themselves in the short term and don't worry. The other way I look at it is to compare the capital investment (exposure) as the portfolio balance... thereby not being swayed by the profit element. | sogoesit | |
10/6/2017 17:31 | ps My holding is about 20% of the portfolio and it is a worrying level. | apad | |
10/6/2017 17:30 | S, it seems to me that the only way to monitor FEVR's success or failure in the future is to monitor its penetration into the US market. This implies trade journals, not share journals. Do you have any notion of how to do this? apad | apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions